Stay updated on VS-6766 and Everolimus Clinical Trial
Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.

Latest updates to the VS-6766 and Everolimus Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page metadata revision/version number has been incremented from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check29 days agoChange DetectedAdded a Lancet Oncology publication citation for the VS-6766 study with an erratum. Removed the old revision note and updated the record to revision v3.5.2 (replacing v3.5.0).SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision history updated: added 'Revision: v3.4.3' and removed 'Revision: v3.4.2'.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision: v3.4.2 was added, and the earlier government funding/operating-status notices (v3.4.1) were removed.SummaryDifference0.4%

- Check100 days agoChange DetectedA government funding notice was added at the top of the page stating potential delays and that the NIH Clinical Center is open. The recruitment status indicator 'Active, not recruiting' was removed, and the page includes a revision notice (Revision: v3.4.1) with updated dates in January 2026.SummaryDifference0.9%

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.